Twentyeight Health, a digital-first women's healthcare platform, has strengthened its market position with a $10 million Series A funding round led by Seae Ventures, bringing its total funding to $25 million. The company simultaneously announced strategic partnerships with major Medicaid insurers Aetna, AmeriHealth, and Molina, expanding its reach in addressing reproductive healthcare access challenges.

"45% of American women seeking reproductive health services face significant challenges in accessing care, especially the 19 million living in contraceptive and maternity care deserts where options are few," stated Bruno Van Tuykom, CEO and Co-Founder of Twentyeight Health. "Our new funding and payer partnerships will bridge this gap, helping women receive the essential care they need, regardless of geography, income, race, age, or coverage status."

The platform has demonstrated significant growth, surpassing 100,000 users in October 2024. Its services encompass a comprehensive range of reproductive health needs, including birth control options, emergency contraception, and prenatal vitamins, often provided without copays through insurance partnerships. Recent data shows increased platform engagement, with a 52% rise in overall conversion and doubled emergency contraception sales following the November presidential election.

Twentyeight Health's impact is particularly notable among underserved populations. Half of its users earn less than $20,000 annually, and three in five users are considered underserved. The platform serves a diverse demographic, with nearly three in five users identifying as people of color. Significantly, 65% of users previously lacked access to birth control, and two in five do not have a primary care provider outside the platform.

Arianne Kidder, Partner at Seae Ventures, emphasized the significance of the funding: "Raising $10 million in this economic climate is no small feat, reflecting both the resilience and relevance of Twentyeight Health's mission. With Medicaid spending $200 billion annually on women's health for reproductive age women, we see real potential in the company's platform and approach."

The company's expansion has been supported by strategic moves, including a partnership with Converge in Mississippi and patient asset acquisitions from SimpleHealth and The Pill Club, further extending its reach in addressing reproductive healthcare needs across the United States.